Protective effects of Fufang Xueshuantong on diabetic retinopathy in rats

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Duan, Huihui ^a   Huang, Jianmei ^a   Li, Wei ^a   Tang, Minke ^a  

^a BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE REDUCTASE; ANTIDIABETIC AGENT; CHINESE DRUG; FUFANG XUESHUANTONG; GLUCOSE; INTERCELLULAR ADHESION MOLECULE 1; OCCLUDIN; PIGMENT EPITHELIUM DERIVED FACTOR; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE DEHYDROGENASE; STREPTOZOCIN; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATARACT; CONTROLLED STUDY; DIABETIC RETINOPATHY; DRUG EFFECT; ENZYME ACTIVITY; ERYTHROCYTE AGGREGATION; FEEDING; GLUCOSE BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; MALE; MORPHOLOGY; NONHUMAN; PERICYTE; PLASMA VISCOSITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RETINA BLOOD VESSEL; RETINA CAPILLARY; RETINA VEIN; STIMULATION; VEIN DILATATION; WEIGHT GAIN; WESTERN BLOTTING;

EID: 84885465976     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/408268     Document Type: Article

References (36)

1. Bucolo C., Ward K. W., Mazzon E., Cuzzocrea S., Drago F., Protective effects of a coumarin derivative in diabetic rats. Investigative Ophthalmology and Visual Science 2009 50 8 3846 3852 2-s2.0-68349104279 10.1167/iovs.08-3328
2. Villarroel M., Ciudin A., Hernandez C., Simo R., Neurodegeneration: an early event of diabetic retinopathy. World Journal of Diabetes 2010 1 2 57 64
3. Malone J. I., Morrison A. D., Pavan P. R., Cuthbertson D. D., Prevalence and significance of retinopathy in subjects with type 1 diabetes of less than 5 years' duration screened for the diabetes control and complications trial. Diabetes Care 2001 24 3 522 526 2-s2.0-0035096883 (Pubitemid 32198424)
4. Crawford T. N., Alfaro D. V. III, Kerrison J. B., Jablon E. P., Diabetic retinopathy and angiogenesis. Current Diabetes Reviews 2009 5 1 8 13 2-s2.0-65549111100 10.2174/157339909787314149
5. Anand-Apte B., Ebrahem Q., Cutler A., Farage E., Sugimoto M., Hollyfield J., Folkman J., Betacellulin induces increased retinal vascular permeability in mice. PLoS ONE 2010 5 10 2-s2.0-78149441695 10.1371/journal.pone.0013444 e13444
6. Zheng L., Szabó C., Kern T. S., Poly(ADP-ribose) polymerase is involved in the development of diabetic retinopathy via regulation of nuclear factor- B. Diabetes 2004 53 11 2960 2967 2-s2.0-7044229731 10.2337/diabetes.53. 11.2960 (Pubitemid 39425922)
7. Kowalczuk L., Touchard E., Omri S., Jonet L., Klein C., Valamanes F., Berdugo M., Bigey P., Massin P., Jeanny J.-C., Behar-Cohen F., Placental growth factor contributes to micro-vascular abnormalization and blood-retinal barrier breakdown in diabetic retinopathy. PLoS ONE 2011 6 3 2-s2.0-79952379454 10.1371/journal.pone.0017462 e17462
8. Cavallerano J. D., Silva P. S., Tolson A. M., Eagan S., Patel B., Aiello L. M., Francis T., Aiello L. P., Tolls D., Imager evaluation of diabetic retinopathy at the time of imaging in a telemedicine program. Diabetes Care 2012 35 3 482 484 2-s2.0-84859092327 10.2337/dc11-1317
9. Rein D. B., Wittenborn J. S., Zhang X., Allaire B. A., Song M. S., Klein R., Saaddine J. B., The cost-effectiveness of three screening alternatives for people with diabetes with no or early diabetic retinopathy. Health Services Research 2011 46 5 1534 1561 2-s2.0-80052528866 10.1111/j.1475-6773.2011.01263.x
10. Gardner T. W., Abcouwer S. F., Barber A. J., Jackson G. R., An integrated approach to diabetic retinopathy research. Archives of Ophthalmology 2011 129 2 230 235 2-s2.0-79951643170 10.1001/archophthalmol.2010.362
11. Bucolo C., Marrazzo G., Platania C. B., Fortified extract of red berry, ginkgo biloba, and white willow bark in experimental early diabetic retinopathy. Journal of Diabetes Research 2013 2013 432695 432700
12. Takamura Y., Tomomatsu T., Kubo E., Tsuzuki S., Akagi Y., Role of the polyol pathway in high glucose-induced apoptosis of retinal pericytes and proliferation of endothelial cells. Investigative Ophthalmology and Visual Science 2008 49 7 3216 3223 2-s2.0-48249083387 10.1167/iovs.07-1643
13. Ejaz S., Chekarova I., Ejaz A., Importance of pericytes and mechanisms of pericyte loss during diabetes retinopathy. Diabetes, Obesity and Metabolism 2008 10 1 53 63 2-s2.0-37349105431 10.1111/j.1463-1326.2007.00795.x (Pubitemid 350302431)
14. Miyamoto K., Khosrof S., Bursell S.-E., Moromizato Y., Aiello L. P., Ogura Y., Adamis A. P., Vascular endothelial growth factor (VEGF)-induced retinal vascular permeability is mediated by intercellular adhesion molecule-1 (ICAM-1). American Journal of Pathology 2000 156 5 1733 1739 2-s2.0-0033838925 (Pubitemid 30646710)
15. Bucolo C., Leggio G. M., Drago F., Salomone S., Eriodictyol prevents early retinal and plasma abnormalities in streptozotocin-induced diabetic rats. Biochemical Pharmacology 2012 846 1 88 92 2-s2.0-84859702164 10.1016/j.bcp.2012.03.019
16. Ogata N., Wada M., Otsuji T., Jo N., Tombran-Tink J., Matsumura M., Expression of pigment epithelium-derived factor in normal adult rat eye and experimental choroidal neovascularization. Investigative Ophthalmology and Visual Science 2002 43 4 1168 1175 2-s2.0-0036211549 (Pubitemid 34258289)
17. Hong J., Intervention of compound Xueshuantong Capsule on diabetic retinopathy in hemorrhage period. China Journal of Traditional Chinese Medicine and Pharmacy 2010 25 9 1535 1536
18. Zhang J.-H., Huang X.-L., Huang H.-B., Huang Q.-B., Chen Y.-Y., Kan W.-H., Zhao K.-S., Effects of compound Xueshuantong dripping-pill on the hemorrheology in blood stasis rats and the clotting-time of mice. Chinese Pharmaceutical Journal 2004 39 5 350 352 2-s2.0-3543081484 (Pubitemid 39024789)
19. Cogan D. G., Toussaint D., Kuwabara T., Retinal vascular patterns. IV. Diabetic retinopathy. Archives of Ophthalmology 1961 66 366 378 2-s2.0-33750809382
20. Park K., Chen Y., Hu Y., Mayo A. S., Kompella U. B., Longeras R., Ma J.-X., Nanoparticle-mediated expression of an angiogenic inhibitor ameliorates ischemia-induced retinal neovascularization and diabetes-induced retinal vascular leakage. Diabetes 2009 58 8 1902 1913 2-s2.0-68049142424 10.2337/db08-1327
21. Chen Y., Moiseyev G., Takahashi Y., Ma J.-X., RPE65 gene delivery restores isomerohydrolase activity and prevents early cone loss in Rpe65-/- Mice. Investigative Ophthalmology and Visual Science 2006 47 3 1177 1184 2-s2.0-33645420955 10.1167/iovs.05-0965 (Pubitemid 46768354)
22. de Juan J. A., Moya F. J., Ripodas A., Bernal R., Fernandez-Cruz A., Fernandez-Durango R., Changes in the density and localisation of endothelin receptors in the early stages of rat diabetic retinopathy and the effect of insulin treatment. Diabetologia 2000 43 6 773 785 2-s2.0-0034086829 (Pubitemid 30409153)
23. Akileshwari C., Muthenna P., Nastasijević B., Inhibition of aldose reductase by Gentiana lutea extracts. Experimental Diabetes Research 2012 2012 147965 147972 10.1155/2012/147965
24. Nunes S., Pires I., Rosa A., Duarte L., Bernardes R., Cunha-Vaz J., Microaneurysm turnover is a biomarker for diabetic retinopathy progression to clinically significant macular edema: findings for type 2 diabetics with nonproliferative retinopathy. Ophthalmologica 2009 223 5 292 297 2-s2.0-64549111668 10.1159/000213639
25. Lakshminarayanan S., Gardner T. W., Tarbell J. M., Effect of shear stress on the hydraulic conductivity of cultured bovine retinal microvascular endothelial cell monolayers. Current Eye Research 2000 21 6 944 951 2-s2.0-0034444080 10.1076/ceyr.21.6.944.6985 (Pubitemid 32452707)
26. Wessells H., Teal T. H., Engel K., Sullivan C. J., Gallis B., Tran K. B., Chitaley K., Fluid shear stress-induced nitric oxide production in human cavernosal endothelial cells: inhibition by hyperglycaemia. BJU International 2006 97 5 1047 1052 2-s2.0-33645737807 10.1111/j.1464-410X.2006.06059.x
27. Hammes H.-P., Lin J., Wagner P., Feng Y., Vom Hagen F., Krzizok T., Renner O., Breier G., Brownlee M., Deutsch U., Angiopoietin-2 causes pericyte dropout in the normal retina: evidence for involvement in diabetic retinopathy. Diabetes 2004 53 4 1104 1110 2-s2.0-12144286666 10.2337/diabetes.53.4.1104 (Pubitemid 38436625)
28. Arden G. B., Sivaprasad S., Hypoxia and oxidative stress in the causation of diabetic retinopathy. Current Diabetes Reviews 2011 7 5 291 304 2-s2.0-80053471739
29. Wright W. S., McElhatten R. M., Harris N. R., Increase in retinal hypoxia-inducible factor-2 α but not hypoxia, early in the progression of diabetes in the rat. Experimental Eye Research 2011 93 4 437 441 2-s2.0-80055030000 10.1016/j.exer.2011.06.003
30. Barouch F. C., Miyamoto K., Allport J. R., Fujita K., Bursell S.-E., Aiello L. P., Luscinskas F. W., Adamis A. P., Integrin-mediated neutrophil adhesion and retinal leukostasis in diabetes. Investigative Ophthalmology and Visual Science 2000 41 5 1153 1158 2-s2.0-0034114618 (Pubitemid 30187554)
31. Miyamoto K., Khosrof S., Bursell S.-E., Rohan R., Murata T., Clermont A. C., Aiello L. P., Ogura Y., Adamis A. P., Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition. Proceedings of the National Academy of Sciences of the United States of America 1999 96 19 10836 10841 2-s2.0-0032863021 10.1073/pnas.96.19.10836 (Pubitemid 29442230)
32. Antonetti D. A., Barber A. J., Hollinger L. A., Wolpert E. B., Gardner T. W., Vascular endothelial growth factor induces rapid phosphorylation of tight junction proteins occludin and zonula occluden 1. A potential mechanism for vascular permeability in diabetic retinopathy and tumors. The Journal of Biological Chemistry 1999 274 33 23463 23467 2-s2.0-0033551811 10.1074/jbc.274.33.23463 (Pubitemid 29388102)
33. Klaassen I., Hughes J. M., Vogels I. M. C., Schalkwijk C. G., van Noorden C. J. F., Schlingemann R. O., Altered expression of genes related to blood-retina barrier disruption in streptozotocin-induced diabetes. Experimental Eye Research 2009 89 1 4 15 2-s2.0-67349236067 10.1016/j.exer.2009.01.006
34. Janghorbani M., Jones R. B., Allison S. P., Incidence of and risk factors for cataract among diabetes clinic attenders. Ophthalmic Epidemiology 2000 7 1 13 25 2-s2.0-0034099446 (Pubitemid 30168943)
35. Arnal E., Miranda M., Almansa I., Muriach M., Barcia J. M., Romero F. J., Diaz-Llopis M., Bosch-Morell F., Lutein prevents cataract development and progression in diabetic rats. Graefe's Archive for Clinical and Experimental Ophthalmology 2009 247 1 115 120 2-s2.0-56949105830 10.1007/s00417-008-0935-z
36. Esteves F. P., Sanyal R., Nye J. A., Santana C. A., Verdes L., Raggia P., Adenosine stress rubidium-82 PET/computed tomography in patients with known and suspected coronary artery disease. Nuclear Medicine Communications 2008 29 8 674 678 2-s2.0-55249084656 10.1097/MNM.0b013e328301a614